Allergan says a trial for its migraine drug succeeds
February 06, 2018 at 07:02 AM EST
Allergan released top-line results of the ACHIEVE I study for treating migraines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.